What did TPG / AmerisourceBergen pay for OneOncology?

TPG / AmerisourceBergen acquired OneOncology for $2.10B in 2023 (19.0x EBITDA). Target EBITDA was approximately $110.5M.

What does OneOncology do?

OneOncology is a medical practice specialty business.

What multiple did TPG / AmerisourceBergen pay for OneOncology?

19.0x EBITDA, based on disclosed deal value of $2.10B and disclosed financials.

M&A TRANSACTION · 2023

OneOncology acquired by TPG / AmerisourceBergen

$2.10B· 19.0x EBITDA

Target

OneOncology

Acquirer

TPG / AmerisourceBergen

Disclosed financials at time of acquisition

Revenue

—

EBITDA

$110.5M

Deal Value

$2.10B

EV/EBITDA

19.0x

Context

This $2.10B acquisition of OneOncology by TPG / AmerisourceBergen sits in the medical practice specialty sub-vertical. The 19.0x EBITDA multiple paid in 2023 can be compared against the population median for medical practice specialty transactions of similar size on our Medical Practice Specialty valuation hub.

Source

Data sourced from Press release. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical practice specialty

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the OneOncology acquisition.

Citation: ExitValue.ai. (2023). OneOncology acquired by TPG / AmerisourceBergen. https://exitvalue.ai/deals/oneoncology-acquired-by-tpg-amerisourcebergen-hc-2023-0048